US Stock MarketDetailed Quotes

VAL Valaris

Watchlist
  • 46.470
  • +1.210+2.67%
Close Jan 7 16:00 ET
  • 46.470
  • 0.0000.00%
Post 17:46 ET
3.30BMarket Cap3.23P/E (TTM)

Valaris Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Valaris Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 588.595M--
--2024/Q4-- / 578.527M--
Oct 31, 20242024/Q3643.100M / 620.119M--
Aug 1, 20242024/Q2610.100M / 578.791M--
May 2, 20242024/Q1525.000M / 498.973M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 588.595M--
--2024/Q4-- / 578.527M--
Oct 31, 20242024/Q3643.100M / 620.119M--
Aug 1, 20242024/Q2610.100M / 578.791M--
May 2, 20242024/Q1525.000M / 498.973M--

Unlock Free Earnings Estimates

Valaris Earnings Reports

  • Valaris | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 11:15 ET

  • Valaris | 8-K: Valaris Reports Third Quarter 2024 Results

    Oct 30, 2024 16:43 ET

  • Valaris | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 11:01 ET

  • Valaris | 8-K: Valaris Reports Second Quarter 2024 Results

    Jul 31, 2024 16:19 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Precision Drilling
    PDS
    +4.64%
    Lantheus
    LNTH
    +3.30%
    Dorian LPG
    LPG
    +2.38%
    Collegium Pharmaceutical
    COLL
    +1.82%
    Halozyme Therapeutics
    HALO
    +1.35%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Hold

    • Buy

      28.57%

    • Hold

      57.14%

    • Sell

      14.29%

    Price Target

    No Data